Testing effectiveness (Phase 2)Study completedNCT02398435What this trial is testingTherapeutic Use of Tadekinig Alfa in Adult-onset Still's DiseaseWho this might be right forStill's Disease, Adult-Onset AB2 Bio Ltd. 23
Not applicableEnded earlyNCT00868751What this trial is testingSingle Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic ArthritisWho this might be right forArthritis, Juvenile RheumatoidStill's Disease, Juvenile Onset Tufts Medical Center 1
Large-scale testing (Phase 3)Study completedNCT00277251What this trial is testingAlendronate Osteoporosis StudyWho this might be right forGlucocorticoid-Associated Osteopenia and Osteoporosis Boston Children's Hospital 20
Not applicableUnknownNCT03651193What this trial is testingMulti-center Registration Study of Adult Onset Still's Disease in Chinese PopulationWho this might be right forAdult Onset Still Disease Second Xiangya Hospital of Central South University 150
Testing effectiveness (Phase 2)Study completedNCT00570661What this trial is testingOpen Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic ArthritisWho this might be right forActive SystemicOnset Juvenile Idiopathic Arthritis Italfarmaco 17
Not applicableNot Yet RecruitingNCT07126145What this trial is testingClinical Autoinflammatory Disease CohortWho this might be right forStill DiseaseAutoinflammatory Disease RenJi Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT05001737What this trial is testingEvaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLEWho this might be right forMacrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more Swedish Orphan Biovitrum 33
Testing effectiveness (Phase 2)UnknownNCT01002781What this trial is testingEfficacy and Safety of Tocilizumab in Adult's Still DiseaseWho this might be right forAdult's Still Disease Tel-Aviv Sourasky Medical Center 10
Not applicableLooking for participantsNCT05927454What this trial is testingAcostill ( RaDiCo Cohort) (RaDiCo Acostill)Who this might be right forStill DiseaseStill's Disease, Adult-OnsetStill Disease, Juvenile Onset Institut National de la Santé Et de la Recherche Médicale, France 500
Very early researchUnknownNCT05239702What this trial is testingClinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesWho this might be right forCrohn DiseaseUlcerative ColitisDermatomyositis+2 more Zhejiang University 75
Not applicableStudy completedNCT03932344What this trial is testingLong-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)Who this might be right forStill Disease, Juvenile Onset Swedish Orphan Biovitrum 306
Not applicableStudy completedNCT06405152What this trial is testingAssessment of Macrophage Activation syndromE in STill's DiseaseWho this might be right forMacrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset Swedish Orphan Biovitrum 75
Not applicableStudy completedNCT06992505What this trial is testingAssessment of Macrophage Activation syndromE in STill's Disease in ItalyWho this might be right forMacrophage Activation Syndrome (MAS)Still Disease, Juvenile OnsetStill's Disease, Adult-Onset Swedish Orphan Biovitrum 32
Not applicableUnknownNCT01095146What this trial is testingNew Candidate Criteria for Diagnosis of Macrophage Activation SyndromeWho this might be right forMacrophage Activation SyndromeLymphohistiocytosis, Hemophagocytic Amrita Institute of Medical Sciences & Research Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT07203001What this trial is testingA Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseWho this might be right forStill´s Disease Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Ended earlyNCT03265132What this trial is testingEvaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)Who this might be right forStill's Disease, Adult-OnsetStill's Disease, Juvenile-Onset Swedish Orphan Biovitrum 13
Not applicableNot Yet RecruitingNCT07077304What this trial is testingEACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesWho this might be right forMyocarditisANCA Associated VasculitisPericarditis+10 more Assistance Publique - Hôpitaux de Paris 5,000
Not applicableLooking for participantsNCT05200715What this trial is testingAutoInflammatory Disease Alliance Registry (AIDA)Who this might be right forHereditary Autoinflammatory DiseasesSchnitzler SyndromeBehcet Syndrome+8 more University of Siena 3,500
Testing effectiveness (Phase 2)Study completedNCT03311854What this trial is testingInvestigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)Who this might be right forMacrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more Swedish Orphan Biovitrum 14
Not applicableLooking for participantsNCT03510442What this trial is testingNatural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsWho this might be right forStill's Disease, Adult-OnsetSystemic InflammationArthritis+1 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000